Publish date:

WPI: Watson Pharmaceuticals Cautions on Earnings


Watson Pharmaceuticals


yesterday cautioned investors that it would report third-quarter cash earnings between 12 to 14 cents a share and GAAP earnings between 3 to 5 cents a share.

The 10-analyst estimate forecasts the company to post a 48-cent profit for the quarter. Watson blamed weak product sales associated with its purchase of

TheStreet Recommends

Schein Pharmaceuticals

, as well as pricing competition and operating expenses on the earnings shortfall.